Advertising

Day 2 at Lions Health: Watson's got its eye on you, Cannes

Day 2 at Lions Health: Watson's got its eye on you, Cannes

There's much for marketers to glean from stepping into different environments, working with new partners, and putting assets to work in new ways, said one speaker.

Lions Health: The 2017 pharma winners

Lions Health: The 2017 pharma winners

A public health campaign developed by McCann Health India for children in Afghanistan was the big winner in 2017.

U.S. campaigns make up one-third of Lions Health pharma shortlist

U.S. campaigns make up one-third of Lions Health pharma shortlist

By

In the Lions Health pharma shortlist, released Saturday morning, five branded campaign made it through the judging process for the branded prescription categories.

CDM New York's Carolyn O'Neill on 'femvertising'

CDM New York's Carolyn O'Neill on 'femvertising'

"Other brands have missed the mark, with an apparent belief that once you hashtag it, they will come," she writes.

Roundtable: When it comes to media, pharma compares the new with the old

Roundtable: When it comes to media, pharma compares the new with the old

By

In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.

Will We See You in Cannes?

Will We See You in Cannes?

By

MM&M's Live @ Cannes coverage, starting today, is abuzz with stories about all things newsworthy and trending leading up to and during the two-day event.

Healthcare brands turn to emotion, to better tell their stories

Healthcare brands turn to emotion, to better tell their stories

By

It's never been easy for pharmaceutical companies or healthcare brands to authentically engage with patients or with doctors.

How Ritesh Patel does Cannes

How Ritesh Patel does Cannes

Words of the wise: Vacant the Gutter Bar by 2 a.m., and make sure to bring flip flops and go walk on the beach.

How Graham Mills does Cannes

How Graham Mills does Cannes

He buys macarons to make friends and finds that Cannes is an "extraordinary opportunity to rewire your brain."

23andMe partners with 'Despicable Me 3' for first movie partnership

23andMe partners with 'Despicable Me 3' for first movie partnership

By

The genetics testing company helps Gru find his lost-lost brother in six-week marketing push.

5 Ways to Engage in Powerful Storytelling, in a Fragmented Media Environment

5 Ways to Engage in Powerful Storytelling, in a Fragmented Media Environment

Too often marketers get caught up in their own company, brand, or workforce as the hero of their own story.

Physicians call for DTC ads to include retail prices

Physicians call for DTC ads to include retail prices

By

They are asking the American Medical Association to support the policy proposal.

Five things for pharma marketers to know: Friday, June 2, 2017

Five things for pharma marketers to know: Friday, June 2, 2017

By

Oncologists more likely to prescribe drugs when receiving travel, meal payments; Tesaro reportedly considering a sale; AbbVie has best pharma reputation

Outcome Health raises $500 million in financing round

Outcome Health raises $500 million in financing round

By

The deal highlights ongoing interest in the influential point-of-care market.

Five things for pharma marketers to know: Tuesday, May 23, 2017

Five things for pharma marketers to know: Tuesday, May 23, 2017

By

Disease awareness ads can boost drug sales; AstraZeneca's experimental asthma drug cuts steroid use; FDA approves Regeneron and Sanofi's RA drug

Study: One-third of docs trust pharma content on HCP sites

Study: One-third of docs trust pharma content on HCP sites

By

In general, physicians believe that information provided by pharma companies is difficult to find and lacking in science.

As sensitivities rise, the diversity officer's role expands

As sensitivities rise, the diversity officer's role expands

By

In the wake of high-profile brand flops, everyone from clients to creative teams seeks the counsel of experts.

Five things for pharma marketers to know: Thursday, April 20, 2017

Five things for pharma marketers to know: Thursday, April 20, 2017

By

Tesaro discloses price for new drug that differs from FDA-approved dosage; uniQure discontinues Glybera; O'Reilly leaves Fox

PhRMA debuts new ads in Go Boldly campaign

PhRMA debuts new ads in Go Boldly campaign

By

PhRMA worked with WPP Health & Wellness and Young & Rubicam on creative for the ads.

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

By

This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.

Gilead, Astellas also suspend ads on 'The O'Reilly Factor'

Gilead, Astellas also suspend ads on 'The O'Reilly Factor'

By

Bayer, Eli Lilly, GlaxoSmithKline, and Sanofi have suspended advertising on the show, according to news reports.

Five things for pharma marketers to know: Wednesday, April 5, 2017

Five things for pharma marketers to know: Wednesday, April 5, 2017

By

GSK pulls ads from "The O'Reilly Factor"; the FDA approves drug for Huntington's disease patients; lawmakers may remove pre-existing conditions requirement

McCann Health's June Laffey on Why Change is Good in Health

McCann Health's June Laffey on Why Change is Good in Health

The president of the 2017 Lions Health pharma jury shares campaigns that incorporate technology, innovation, and creative thinking to impact behaviors and change lives.

Drummy passes the torch at Heartbeat, moves to chairman role

Drummy passes the torch at Heartbeat, moves to chairman role

By

Agency vets Nadine Leonard and James Talerico to co-lead Publicis-owned shop.

The DTC Ads of 2016 That Shouldn't Have Happened

The DTC Ads of 2016 That Shouldn't Have Happened

By

Pharma marketers are producing plenty of exceptional creative work in the DTC realm. There are also plenty that prompt quick checks to make sure that one hasn't inadvertently clicked over to The Onion.

The Top 10 DTC Ads of 2016

The Top 10 DTC Ads of 2016

Mary Skoyles finds that DTC ads are getting better. "There's a lot of interesting work being done," she says. "There are more chances being taken."

The 2017 DTC Report: All the data in one place

The 2017 DTC Report: All the data in one place

Drugmakers again spent more on DTC advertising in 2016 than the year before.

Five things for pharma marketers to know: Friday, March 17, 2017

Five things for pharma marketers to know: Friday, March 17, 2017

By

The FDA delays final rule related to off-label use; Amgen's Repatha reduces risk of death by 20%, study finds; FDA rejects AstraZeneca's hyperkalaemia drug

MSCG's Mark Friedman on Ads with Animals

MSCG's Mark Friedman on Ads with Animals

The chief creative officer takes a look at campaigns in and outside the U.S.

Doctors seek more transparency from drugmakers: ePharma panel

Doctors seek more transparency from drugmakers: ePharma panel

By

Pharmaceutical companies often blur the lines between a drug's risks and benefits in ads, and that frustrates physicians.